Monday, Dec 18, 2017
engineered enzymes for better healthcare
Paul_Engel
  • Biochemist with over 40 years of research experience in Biochemistry
  • Professor of Biochemistry at University College Dublin
  • Co-founder of the Conway Institute of Biomolecular and Biomedical Research (UCD)
  • Former Director of the Krebs Institute for Biomolecular Research (Sheffield, UK)
  • Elected Member of the Royal Irish Academy
  • Chairman of Life Sciences Committee of the Royal Irish Academy
  • Author of more than 150 research publications, 4 books and 3 Patents
  • Current holder of €2 million Fellowship grant from Science Foundation Ireland for enzyme engineering research.

Language Selection

Search

Latest News

Newborn Screening - First Steps into the marketplace
Irish technology to enable metabolic disorder screening among newborns in the developing world and remote locations... Read full article on the web Technology…

Read more...

Screen your baby’s health
Enzolve Technologies recently launched a novel newborn screening test for Phenylketonuria (PKU), an inherited metabolic disorder that results in severe mental…

Read more...

UCD campus company to begin production of newborn screening kits for international markets
Enzolve Technologies has recently secured substantial investment from Enterprise Ireland to allow them to begin immediate production of diagnostic screening kits…

Read more...